The University of Chicago Header Logo

David Kim

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Hospital Medicine
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    David D. Kim, PhD, is an Assistant Professor of Medicine and Public Health Sciences at the University of Chicago. Previously, he served as an Assistant Professor and Program Director of the Cost-Effectiveness Analysis Registry at the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center. As a health economist, Dr. Kim's primary focus centers around measuring the value of health interventions and providing guidance for value-based health care decisions. His extensive research encompasses three key areas: (1) evaluating long-term health, equity, and economic impact of health interventions using simulation modeling; (2) measuring the use and consequences of low-value care; (3) enhancing methodology in economic evaluation and research prioritization. He has written several pieces highlighting the gap between guideline recommendations and actual practice in cost-effectiveness analysis with future directions for improvement. Recognizing the need for reliable tools to facilitate value-based decision-making, he has developed a formal quality assessment tool for cost-effectiveness analysis, called the Criteria for Health Economic Quality Evaluation (CHEQUE) tool. He has also created a decision framework and checklist to assess the transferability of economic evaluations. Dr. Kim received his PhD in Health Economics from the University of Washington and holds a Master's degree in Biostatistics from the University of Michigan.

    Collapse Biography 
    Collapse education and training
    University of Washington, SeattlePhD08/2016Health Economics
    University of Michigan, Ann ArborMS05/2012Biostatistics
    University of Michigan, Ann Arbor BSE05/2009Biomedical Engineering

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kim DD. The role of simulation modelling in public health policy evaluation. Lancet Public Health. 2024 Mar; 9(3):e150-e151. PMID: 38429013.
      Citations:    Fields:    Translation:Humans
    2. Kim DD, Wang L, Lauren BN, Liu J, Marklund M, Lee Y, Micha R, Mozaffarian D, Wong JB. Development and Validation of the US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model: Health Disparity and Economic Impact Model. Med Decis Making. 2023 Oct-Nov; 43(7-8):930-948. PMID: 37842820; PMCID: PMC10625721.
      Citations: 1     Fields:    Translation:Humans
    3. Wang L, Lauren BN, Hager K, Zhang FF, Wong JB, Kim DD, Mozaffarian D. Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study. J Am Heart Assoc. 2023 08; 12(15):e029215. PMID: 37417296; PMCID: PMC10492976.
      Citations: 2     Fields:    Translation:Humans
    4. Kim DD. Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy. Pharmacoeconomics. 2023 09; 41(9):1151-1164. PMID: 37195368; PMCID: PMC10189225.
      Citations:    Fields:    Translation:Humans
    5. Neumann PJ, Kim DD. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JAMA. 2023 04 18; 329(15):1312-1314. PMID: 37071104; PMCID: PMC10114019.
      Citations: 7     Fields:    
    6. Du M, Griecci CF, Cudhea F, Eom H, Wong JB, Wilde P, Kim DD, Michaud DS, Wang YC, Mozaffarian D, Zhang FF, Food-PRICE Project. What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA. BMJ Open. 2023 04 18; 13(4):e063614. PMID: 37072239; PMCID: PMC10186398.
      Citations: 1     Fields:    Translation:Humans
    7. Kim DD, Do LA, Synnott PG, Lavelle TA, Prosser LA, Wong JB, Neumann PJ. Developing Criteria for Health Economic Quality Evaluation Tool. Value Health. 2023 08; 26(8):1225-1234. PMID: 37068557.
      Citations: 5     Fields:    Translation:Humans
    8. Baig K, Dusetzina SB, Kim DD, Leech AA. Medicare Part D Coverage of Antiobesity Medications - Challenges and Uncertainty Ahead. N Engl J Med. 2023 Mar 16; 388(11):961-963. PMID: 36912541.
      Citations: 10     Fields:    Translation:Humans
    9. Kim DD, Daly AT, Koethe BC, Fendrick AM, Ollendorf DA, Wong JB, Neumann PJ. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending. JAMA Netw Open. 2022 11 01; 5(11):e2243449. PMID: 36413364; PMCID: PMC9682424.
      Citations: 2     Fields:    Translation:Humans
    10. Do LA, Koethe BC, Daly AT, Chambers JD, Ollendorf DA, Wong JB, Fendrick AM, Neumann PJ, Kim DD. State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations. Health Aff (Millwood). 2022 09; 41(9):1281-1290. PMID: 36067429.
      Citations: 2     Fields:    Translation:Humans
    11. Zhu Y, Koethe B, Ollendorf DA, Wong JB, Neumann PJ, Kim DD. Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population. Med Care. 2022 12 01; 60(12):888-894. PMID: 36038520.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. O'Hearn M, Lauren BN, Wong JB, Kim DD, Mozaffarian D. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. J Am Coll Cardiol. 2022 07 12; 80(2):138-151. PMID: 35798448; PMCID: PMC10475326.
      Citations: 33     Fields:    Translation:Humans
    13. Podolsky MI, Present I, Neumann PJ, Kim DD. A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues. Value Health. 2022 08; 25(8):1298-1306. PMID: 35398012; PMCID: PMC8986127.
      Citations: 7     Fields:    Translation:Humans
    14. Ma S, Olchanski N, Cohen JT, Ollendorf DA, Neumann PJ, Kim DD. The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies. Value Health. 2022 08; 25(8):1336-1343. PMID: 35315331.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    15. Silver MC, Neumann PJ, Ma S, Kim DD, Cohen JT, Nyaku M, Roberts C, Sinha A, Ollendorf DA. Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines. Vaccine. 2021 11 05; 39(46):6727-6734. PMID: 34656380.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    16. Kim DD, Basu A. How Does Cost-Effectiveness Analysis Inform Health Care Decisions? AMA J Ethics. 2021 08 01; 23(8):E639-647. PMID: 34459732.
      Citations: 12     Fields:    Translation:Humans
    17. van Dover TJ, Kim DD. Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence? Value Health. 2021 11; 24(11):1586-1591. PMID: 34711358.
      Citations: 3     Fields:    Translation:Humans
    18. Du M, Griecci CF, Cudhea FF, Eom H, Kim DD, Wilde P, Wong JB, Wang YC, Michaud DS, Mozaffarian D, Zhang F, Food-PRICE Project. Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US. JAMA Netw Open. 2021 04 01; 4(4):e217501. PMID: 33904914; PMCID: PMC8080223.
      Citations: 4     Fields:    Translation:Humans
    19. Kim DD, Do LA, Daly AT, Wong JB, Chambers JD, Ollendorf DA, Neumann PJ. An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence Considered. J Gen Intern Med. 2021 11; 36(11):3448-3455. PMID: 33620623; PMCID: PMC8606489.
      Citations: 6     Fields:    Translation:Humans
    20. Hendrix N, Kim DD, Patel KS, Devine B. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses. Med Decis Making. 2021 04; 41(3):366-372. PMID: 33451278; PMCID: PMC7987800.
      Citations: 1     Fields:    Translation:Humans
    21. Neumann PJ, Cohen JT, Kim DD, Ollendorf DA. Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic. Health Aff (Millwood). 2021 01; 40(1):53-61. PMID: 33211534.
      Citations: 16     Fields:    Translation:Humans
    22. Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018. Pharmacoeconomics. 2020 10; 38(10):1135-1145. PMID: 32696192; PMCID: PMC7373843.
      Citations: 64     Fields:    Translation:Humans
    23. Gicas KM, Cheng A, Panenka WJ, Kim DD, Yau JC, Procyshyn RM, Stubbs JL, Jones AA, Bains S, Thornton AE, Lang DJ, Vertinsky AT, Rauscher A, Honer WG, Barr AM. Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults. Prog Neuropsychopharmacol Biol Psychiatry. 2021 03 02; 106:110084. PMID: 32890696.
      Citations: 5     Fields:    Translation:HumansAnimals
    24. Kim DD, Ollendorf DA, Neumann PJ, Fendrick AM. Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency? Am J Manag Care. 2020 09; 26(9):369-370. PMID: 32930548.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    25. Du M, Griecci CF, Kim DD, Cudhea F, Ruan M, Eom H, Wong JB, Wilde PE, Michaud DS, Lee Y, Micha R, Mozaffarian D, Zhang FF. Cost-Effectiveness of a National Sugar-Sweetened Beverage Tax to Reduce Cancer Burdens and Disparities in the United States. JNCI Cancer Spectr. 2020 Dec; 4(6):pkaa073. PMID: 33409452; PMCID: PMC7771430.
      Citations: 5     Fields:    
    26. Ma S, Kim DD, Cohen JT, Neumann PJ. Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China. Value Health. 2020 11; 23(11):1405-1408. PMID: 33127009; PMCID: PMC7384788.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    27. Panzer AD, Emerson JG, D'Cruz B, Patel A, Dabak S, Isaranuwatchai W, Teerawattananon Y, Ollendorf DA, Neumann PJ, Kim DD. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020 08; 29(8):945-954. PMID: 32412153; PMCID: PMC7383734.
      Citations: 19     Fields:    Translation:Humans
    28. Feng X, Kim DD, Cohen JT, Neumann PJ, Ollendorf DA. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter? Int J Technol Assess Health Care. 2020 Apr; 36(2):96-103. PMID: 32340631.
      Citations: 11     Fields:    Translation:Humans
    29. Kim DD, Neumann PJ. Analyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences. Med Decis Making. 2020 04; 40(3):251-253. PMID: 32428432.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    30. Leech AA, Kim DD, Cohen JT, Neumann PJ. Are low and middle-income countries prioritising high-value healthcare interventions? BMJ Glob Health. 2020; 5(2):e001850. PMID: 32133187; PMCID: PMC7042606.
      Citations: 9     Fields:    Translation:Humans
    31. Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. Pharmacoeconomics. 2020 02; 38(2):171-179. PMID: 31631254.
      Citations:    Fields:    Translation:Humans
    32. Isaranuwatchai W, Teerawattananon Y, Archer RA, Luz A, Sharma M, Rattanavipapong W, Anothaisintawee T, Bacon RL, Bhatia T, Bump J, Chalkidou K, Elshaug AG, Kim DD, Reddiar SK, Nakamura R, Neumann PJ, Shichijo A, Smith PC, Culyer AJ. Prevention of non-communicable disease: best buys, wasted buys, and contestable buys. BMJ. 2020 01 28; 368:m141. PMID: 31992592; PMCID: PMC7190374.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    33. Kim DD, Neumann PJ. Comparative Modeling to Inform Health Policy Decisions: A Step Forward. Ann Intern Med. 2019 12 03; 171(11):851-852. PMID: 31683277.
      Citations: 2     Fields:    Translation:Humans
    34. Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ. Variation in US private health plans' coverage of orphan drugs. Am J Manag Care. 2019 10; 25(10):508-512. PMID: 31622066.
      Citations: 13     Fields:    Translation:Humans
    35. Kim DD, Wilde PE, Michaud DS, Liu J, Lizewski L, Onopa J, Mozaffarian D, Zhang FF, Wong JB. Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S. Am J Prev Med. 2019 11; 57(5):e143-e152. PMID: 31564600; PMCID: PMC6803059.
      Citations: 12     Fields:    Translation:Humans
    36. Zhang FF, Cudhea F, Shan Z, Michaud DS, Imamura F, Eom H, Ruan M, Rehm CD, Liu J, Du M, Kim D, Lizewski L, Wilde P, Mozaffarian D. Preventable Cancer Burden Associated With Poor Diet in the United States. JNCI Cancer Spectr. 2019 Jun; 3(2):pkz034. PMID: 31360907; PMCID: PMC6649723.
      Citations: 65     Fields:    
    37. Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Glob Health. 2019; 4(3):e001418. PMID: 31179038; PMCID: PMC6528776.
      Citations: 11     Fields:    
    38. Emerson J, Panzer A, Cohen JT, Chalkidou K, Teerawattananon Y, Sculpher M, Wilkinson T, Walker D, Neumann PJ, Kim DD. Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS One. 2019; 14(5):e0205633. PMID: 31042714; PMCID: PMC6493721.
      Citations: 14     Fields:    
    39. Kim DD, Trikalinos TA, Wong JB. Leveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical Research. Med Decis Making. 2019 02; 39(2):119-129. PMID: 30678537.
      Citations: 2     Fields:    Translation:Humans
    40. Kim DD, Cohen JT, Wong JB, Mohit B, Fendrick AM, Kent DM, Neumann PJ. Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency. Health Aff (Millwood). 2019 01; 38(1):60-67. PMID: 30615528; PMCID: PMC6409129.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    41. Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Med Decis Making. 2018 10; 38(7):767-777. PMID: 30248277.
      Citations: 32     Fields:    Translation:Humans
    42. Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD. Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Med. 2018 09; 7(9):4251-4260. PMID: 30030904; PMCID: PMC6144145.
      Citations: 6     Fields:    Translation:Humans
    43. Chambers JD, Kim DD, Pope EF, Graff JS, Wilkinson CL, Neumann PJ. Specialty Drug Coverage Varies Across Commercial Health Plans In The US. Health Aff (Millwood). 2018 07; 37(7):1041-1047. PMID: 29985695.
      Citations: 21     Fields:    Translation:Humans
    44. Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 07; 56(7):583-588. PMID: 29762271.
      Citations: 13     Fields:    Translation:Humans
    45. Kim DD, Arterburn DE, Sullivan SD, Basu A. Association Between the Publication of Clinical Evidence and the Use of Bariatric Surgery. Obes Surg. 2018 05; 28(5):1321-1328. PMID: 29086183.
      Citations: 1     Fields:    Translation:Humans
    46. Neumann PJ, Anderson JE, Panzer AD, Pope EF, D'Cruz BN, Kim DD, Cohen JT. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures. Gates Open Res. 2018; 2:5. PMID: 29431169; PMCID: PMC5801595.
      Citations: 13     Fields:    
    47. Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value Health. 2018 07; 21(7):759-761. PMID: 30005746; PMCID: PMC6041503.
      Citations: 71     Fields:    Translation:Humans
    48. Kim DD, Wilkinson CL, Pope EF, Chambers JD, Cohen JT, Neumann PJ. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec; 17(6):615-623. PMID: 28504026.
      Citations: 24     Fields:    Translation:Humans
    49. Kim DD, Basu A. New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives. Med Decis Making. 2017 11; 37(8):930-941. PMID: 28441507.
      Citations: 3     Fields:    Translation:Humans
    50. Kim DD, Basu A. Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value Health. 2016 Jul-Aug; 19(5):602-13. PMID: 27565277.
      Citations: 122     Fields:    Translation:Humans
    51. Kim DD, Hutton DW, Raouf AA, Salama M, Hablas A, Seifeldin IA, Soliman AS. Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence. Glob Public Health. 2015; 10(3):296-317. PMID: 25469976; PMCID: PMC4320005.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    52. Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. Ophthalmology. 2013 Sep; 120(9):1835-42. PMID: 23642372; PMCID: PMC3737388.
      Citations: 19     Fields:    Translation:Humans
    53. Stein JD, Kim DD, Peck WW, Giannetti SM, Hutton DW. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch Ophthalmol. 2012 Apr; 130(4):497-505. PMID: 22332202; PMCID: PMC3324653.
      Citations: 24     Fields:    Translation:Humans
    Kim's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (190)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _